Infantile hemangioma

Overview


Plain-Language Overview

Infantile hemangioma is a common type of benign tumor made up of extra blood vessels that usually appears on the skin of babies. It typically develops within the first few weeks of life and grows rapidly for several months before slowly shrinking over years. These growths mainly affect the skin and soft tissues, often appearing as a red or purple raised area. While most are harmless and cause no pain, some can interfere with important functions depending on their size and location, such as vision or breathing. The condition involves an abnormal buildup of blood vessel cells that form a dense cluster. Parents often notice the lesion becoming more prominent during the early months. The main health impact is cosmetic and, in rare cases, functional impairment.

Clinical Definition

Infantile hemangioma is a benign vascular tumor characterized by a rapid proliferation of capillary endothelial cells shortly after birth, followed by a slow involution phase. It arises due to abnormal angiogenesis and vasculogenesis, likely influenced by hypoxia-induced factors and genetic predisposition. These lesions are the most common tumors of infancy, predominantly involving the skin and subcutaneous tissues. Clinically, they present as well-demarcated, bright red or bluish nodules or plaques that enlarge during the proliferative phase. The major clinical significance lies in potential complications such as ulceration, bleeding, or impairment of vital structures depending on the lesion's location. Histologically, they show densely packed capillaries lined by plump endothelial cells. The natural history includes a proliferative phase followed by spontaneous involution over several years.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.